T2 Biosystems Inc (TTOO)

[mts]

At this point(.15) it absolutely makes no sense to do a RS. What is to be gained? Just to stay on the NASDAQ? What for? Ttoo can make as many deals and sales from the OTC+ as they can from the NASDAQ. Ttoo is now becoming a great takeover target. Great new technology at a bargain basement price. So how does having fewer shares at a higher price really benefit the company. They need to spend the money it takes to go through a RS on sales and advertising.